Jiyang Jiang1, Wei Wen, Perminder S Sachdev. 1. aCentre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales bNeuropsychiatric Institute, Prince of Wales Hospital, Randwick, NSW, Australia.
Abstract
PURPOSE OF REVIEW: As a divergent member of the transforming growth factor-β superfamily, macrophage inhibitory cytokine-1 (MIC-1/GDF15) is an autocrine regulatory molecule that plays important roles in diseases, such as cancer and cardiovascular disorders. More recently, this cytokine has been investigated for its contribution to ageing and age-related cognitive decline. This review aims at summarizing existing findings on the relationships of MIC-1/GDF15 with cognition, brain, and dementia in ageing populations and animal models. RECENT FINDINGS: In community-dwelling samples, higher circulating MIC-1/GDF15 levels were associated with worsening cognitive function and decline from cognitively normal status to mild cognitive impairment or dementia. Higher MIC-1/GDF15 serum levels were also linked to decreased grey matter volumes and white matter integrity. Brain structural changes were shown to mediate the inverse relationships of MIC-1/GDF15 serum levels with cognition. Animal studies indicated that the expression of MIC-1/GDF15 in response to stress was neuroprotective and even promoted neurogenesis. SUMMARY: From the available findings, MIC-1/GDF15 can be considered as a marker of age-related cognitive decline and brain structural changes. Combining MIC-1/GDF15 with other biomarkers may provide clinical diagnostic and prognostic utility. Threshold effects should be considered in future studies.
PURPOSE OF REVIEW: As a divergent member of the transforming growth factor-β superfamily, macrophage inhibitory cytokine-1 (MIC-1/GDF15) is an autocrine regulatory molecule that plays important roles in diseases, such as cancer and cardiovascular disorders. More recently, this cytokine has been investigated for its contribution to ageing and age-related cognitive decline. This review aims at summarizing existing findings on the relationships of MIC-1/GDF15 with cognition, brain, and dementia in ageing populations and animal models. RECENT FINDINGS: In community-dwelling samples, higher circulating MIC-1/GDF15 levels were associated with worsening cognitive function and decline from cognitively normal status to mild cognitive impairment or dementia. Higher MIC-1/GDF15 serum levels were also linked to decreased grey matter volumes and white matter integrity. Brain structural changes were shown to mediate the inverse relationships of MIC-1/GDF15 serum levels with cognition. Animal studies indicated that the expression of MIC-1/GDF15 in response to stress was neuroprotective and even promoted neurogenesis. SUMMARY: From the available findings, MIC-1/GDF15 can be considered as a marker of age-related cognitive decline and brain structural changes. Combining MIC-1/GDF15 with other biomarkers may provide clinical diagnostic and prognostic utility. Threshold effects should be considered in future studies.
Authors: Kelly Virecoulon Giudici; Sophie Guyonnet; John E Morley; Andrew D Nguyen; Geetika Aggarwal; Angelo Parini; Yan Li; Randall J Bateman; Bruno Vellas; Philipe de Souto Barreto Journal: J Gerontol A Biol Sci Med Sci Date: 2022-06-01 Impact factor: 6.591
Authors: Parvin Kumar; Vincent Millischer; J Carlos Villaescusa; Ida A K Nilsson; Claes-Göran Östenson; Martin Schalling; Urban Ösby; Catharina Lavebratt Journal: Sci Rep Date: 2017-08-11 Impact factor: 4.379
Authors: Yuek Ling Chai; Saima Hilal; Jenny P C Chong; Yan Xia Ng; Oi Wah Liew; Xin Xu; Mohammad Kamran Ikram; Narayanaswamy Venketasubramanian; A Mark Richards; Mitchell K P Lai; Christopher P Chen Journal: Medicine (Baltimore) Date: 2016-08 Impact factor: 1.889
Authors: Jac Kee Low; Ananthan Ambikairajah; Kani Shang; David A Brown; Vicky W W Tsai; Samuel N Breit; Tim Karl Journal: PLoS One Date: 2017-01-12 Impact factor: 3.240
Authors: Jiyang Jiang; Anbupalam Thalamuthu; Jennifer E Ho; Anubha Mahajan; Weronica E Ek; David A Brown; Samuel N Breit; Thomas J Wang; Ulf Gyllensten; Ming-Huei Chen; Stefan Enroth; James L Januzzi; Lars Lind; Nicola J Armstrong; John B Kwok; Peter R Schofield; Wei Wen; Julian N Trollor; Åsa Johansson; Andrew P Morris; Ramachandran S Vasan; Perminder S Sachdev; Karen A Mather Journal: Front Genet Date: 2018-03-23 Impact factor: 4.599
Authors: Deirdre A Killebrew; Kimberly S Williams; Youmei Xie; Frank Longo; Rick B Meeker Journal: J Neuroimmune Pharmacol Date: 2021-07-22 Impact factor: 7.285
Authors: Fang Yang; Izabela G Barbosa; Erica L Vieira; Moises E Bauer; Natalia P Rocha; Antonio L Teixeira Journal: Transl Neurosci Date: 2018-03-23 Impact factor: 1.757